Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)

NCT00868465 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Uncomplicated Malaria

Interventions

DRUG: Artemether-Lumefantrine
DRUG: Dihydroartemisinin-piperaquine

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]